Increased by 18% year over year; normalized growth was approximately 16% when excluding political media contributions. Free ...
Raising 2026E Adjusted EBITDAX Guidance by 42% Driven by Strong Oil Prices, Increased Target Synergies and Expected Operating Efficiencies ...
AbivaxAnnounces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results